LYEL
Lyell Immunopharma·NASDAQ
--
--(--)
--
--(--)
LYEL fundamentals
During Q4 2025, Lyell Immunopharma (LYEL) reported revenue of 6.00K, a YoY change of -45.45%. Net income was -140.72M, a YoY change of 26.68%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | 1.26M -- | 3.12M -- | 1.07M -- | 2.31M -- | 2.44M +94.67% | 2.63M -15.72% | 2.75M +157.48% | 2.82M +22.06% | 553.00K -77.38% | 35.74M +1260.01% | 3.00K -99.89% | 48.39M +1614.60% | 65.00K -88.25% | 27.00K -99.92% | 25.00K +733.33% | 13.00K -99.97% | 3.00K -95.38% | 13.00K -51.85% | 34.00K +36.00% | 11.00K -15.38% | 7.00K +133.33% | 8.00K -38.46% | 15.00K -55.88% | 6.00K -45.45% | 36.00K -- |
Sales and Services Revenue | 1.26M -- | 3.12M -- | 1.07M -- | 2.31M -- | 2.44M +94.67% | 2.63M -15.72% | 2.75M +157.48% | 2.82M +22.06% | 553.00K -77.38% | 35.74M +1260.01% | 3.00K -99.89% | 48.39M +1614.60% | 65.00K -88.25% | 27.00K -99.92% | 25.00K +733.33% | 13.00K -99.97% | 3.00K -95.38% | 13.00K -51.85% | 34.00K +36.00% | 11.00K -15.38% | 7.00K +133.33% | 8.00K -38.46% | 15.00K -55.88% | 6.00K -45.45% | 36.00K -- |
Cost of Revenue | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Gross Profit | 1.26M -- | 3.12M -- | 1.07M -- | -5.44M -- | 2.44M +94.67% | 2.63M -15.72% | 2.75M +157.48% | -7.83M -43.79% | 553.00K -77.38% | 35.74M +1260.01% | 3.00K -99.89% | -36.30M -363.68% | 65.00K -88.25% | 27.00K -99.92% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Other Operating Income | -- -- | -- -- | -- -- | 9.43M -- | -- -- | -- -- | -- -- | 2.32M -75.36% | -- -- | -- -- | -- -- | 4.75M +104.56% | -- -- | -- -- | 292.00K -- | 641.00K -86.52% | 1.09M -- | 976.00K -- | 730.00K +150.00% | 513.00K -19.97% | 119.00K -89.08% | -- -- | 1.59M +117.95% | 1.50M +191.81% | -- -- |
Operating Expenses | 34.26M -- | 105.68M -- | 37.91M -- | 51.27M -- | 57.81M +68.75% | 65.33M -38.18% | 51.92M +36.93% | 89.13M +73.86% | 69.13M +19.57% | 73.00M +11.73% | 66.44M +27.98% | 72.92M -18.18% | 62.62M -9.41% | 65.93M -9.68% | 59.36M -10.66% | 60.16M -17.50% | 69.67M +11.26% | 52.52M -20.35% | 51.27M -13.62% | 214.67M +256.82% | 57.49M -17.48% | 47.15M -10.22% | 38.86M -24.21% | 129.15M -39.84% | 272.65M -- |
Selling, General and Administrative Expenses | 8.88M -- | 9.56M -- | 13.57M -- | 14.87M -- | 16.83M +89.54% | 19.11M +99.87% | 21.24M +56.53% | 31.87M +114.36% | 34.42M +104.51% | 30.45M +59.34% | 26.08M +22.80% | 26.35M -17.33% | 19.28M -43.99% | 19.03M -37.51% | 15.51M -40.55% | 13.17M -50.03% | 13.49M -30.01% | 12.26M -35.60% | 11.77M -24.11% | 14.52M +10.29% | 14.05M +4.09% | 9.79M -20.15% | 10.69M -9.19% | 10.62M -26.90% | 45.13M -- |
General and Administrative Expenses | -- -- | -- -- | -- -- | 46.88M -- | -- -- | -- -- | -- -- | 89.06M +89.96% | -- -- | -- -- | -- -- | 117.31M +31.72% | -- -- | -- -- | 15.51M -- | 13.17M -88.78% | 13.49M -- | 12.26M -- | 11.77M -24.11% | 14.52M +10.29% | 14.05M +4.09% | 9.79M -20.15% | 10.69M -9.19% | 10.62M -26.90% | 45.13M -- |
Research and Development Expenses | 25.50M -- | 97.15M -- | 24.50M -- | 35.09M -- | 41.53M +62.86% | 46.45M -52.19% | 31.43M +28.29% | 19.29M -45.04% | 35.83M -13.72% | 43.72M -5.87% | 41.61M +32.37% | 38.03M +97.21% | 44.63M +24.56% | 47.47M +8.58% | 43.85M +5.39% | 46.99M +23.57% | 43.17M -3.26% | 40.26M -15.19% | 39.50M -9.92% | 48.67M +3.56% | 43.45M +0.63% | 34.86M -13.42% | 28.17M -28.68% | 52.20M +7.26% | 158.68M -- |
Loss on Impairment of Other Assets | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 36.45M -- | -- -- | -- -- | -- -- | 5.00M -86.28% | -- -- | -- -- | 0 -- | 0 -100.00% | 13.00M -- | 0 -- | -- -- | 64.30M -- | 0 -100.00% | 1.44M -- | -- -- | 0 -100.00% | -- -- |
Other Operating Expenses | -120.00K -- | -1.03M -- | -158.00K -- | 1.31M -- | -545.00K -354.17% | -223.00K +78.35% | -758.00K -379.75% | 1.53M +16.67% | -1.12M -105.87% | -1.17M -425.11% | -1.25M -65.04% | 3.54M +132.24% | -1.29M -14.80% | -569.00K +51.41% | -- -- | 0 -100.00% | -- -- | -- -- | -- -- | 87.18M -- | -- -- | 1.06M -- | -- -- | 66.33M -23.92% | -- -- |
Operating Income | -33.00M -- | -102.57M -- | -36.84M -- | -39.52M -- | -55.37M -67.77% | -62.71M +38.86% | -49.16M -33.43% | -83.98M -112.49% | -68.58M -23.85% | -37.26M +40.58% | -66.44M -35.14% | -19.78M +76.44% | -62.56M +8.78% | -65.91M -76.87% | -59.04M +11.14% | -59.51M -200.79% | -68.58M -9.62% | -51.53M +21.81% | -50.51M +14.45% | -214.15M -259.86% | -57.37M +16.35% | -47.14M +8.52% | -37.25M +26.24% | -127.64M +40.39% | -269.40M -- |
Non-Operating Income (Loss) | 3.76M -- | 1.91M -- | 1.12M -- | 667.00K -- | 327.00K -91.31% | 112.00K -94.14% | 286.00K -74.56% | 279.00K -58.17% | 432.00K +32.11% | 938.00K +737.50% | -3.82M -1434.62% | 11.39M +3981.36% | -4.40M -1119.21% | 2.02M +114.82% | 8.19M +314.46% | 6.58M -42.23% | 7.91M +279.63% | 5.72M +183.82% | 5.92M -27.66% | 22.21M +237.69% | 5.17M -34.61% | 4.46M -22.08% | -1.59M -126.90% | -13.08M -158.88% | -5.04M -- |
Other Non-Operating Income (Loss) | 1.42M -- | 29.00K -- | 28.00K -- | 46.00K -- | -27.00K -101.90% | -106.00K -465.52% | 16.00K -42.86% | -44.00K -195.65% | 35.00K +229.63% | -14.00K +86.79% | -6.07M -38025.00% | 7.93M +18131.82% | -8.90M -25528.57% | -3.25M -23107.14% | 1.58M +126.01% | -506.00K -106.38% | 1.09M +112.25% | -645.00K +80.15% | -43.00K -102.72% | 17.29M +3517.59% | 1.31M +20.18% | 1.18M +282.95% | -4.86M -11200.00% | -15.76M -191.11% | -18.12M -- |
Net Interest Expense | -2.34M -- | -1.88M -- | -1.10M -- | -621.00K -- | -354.00K +84.88% | -218.00K +88.41% | -270.00K +75.36% | -323.00K +47.99% | -397.00K -12.15% | -952.00K -336.70% | -2.25M -733.70% | -3.45M -969.04% | -4.50M -1032.75% | -5.26M -452.94% | -6.61M -193.56% | -7.08M -105.15% | -6.82M -51.63% | -6.36M -20.90% | -5.96M +9.73% | -4.92M +30.55% | -3.86M +43.36% | -3.28M +48.52% | -3.27M +45.25% | -2.68M +45.61% | -13.08M -- |
Interest Income | 2.34M -- | 1.88M -- | 1.10M -- | 621.00K -- | 354.00K -84.88% | 218.00K -88.41% | 270.00K -75.36% | 323.00K -47.99% | 397.00K +12.15% | 952.00K +336.70% | 2.25M +733.70% | 3.45M +969.04% | 4.50M +1032.75% | 5.26M +452.94% | 6.61M +193.56% | 7.08M +105.15% | 6.82M +51.63% | 6.36M +20.90% | 5.96M -9.73% | 4.92M -30.55% | 3.86M -43.36% | 3.28M -48.52% | 3.27M -45.25% | 2.68M -45.61% | 13.08M -- |
Pretax Income From Continuing Operations | -29.24M -- | -100.66M -- | -35.72M -- | -38.86M -- | -55.04M -88.25% | -62.59M +37.81% | -48.88M -36.83% | -83.71M -115.42% | -68.14M -23.80% | -36.32M +41.97% | -70.25M -43.74% | -8.40M +89.97% | -66.96M +1.74% | -63.89M -75.89% | -50.85M +27.62% | -52.93M -530.34% | -60.67M +9.40% | -45.81M +28.30% | -44.58M +12.33% | -191.94M -262.62% | -52.20M +13.96% | -42.68M +6.82% | -38.85M +12.87% | -140.72M +26.68% | -274.45M -- |
Income Tax Expense | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -29.24M -- | -100.66M -- | -35.72M -- | -38.86M -- | -55.04M -88.25% | -62.59M +37.81% | -48.88M -36.83% | -83.71M -115.42% | -68.14M -23.80% | -36.32M +41.97% | -70.25M -43.74% | -8.40M +89.97% | -66.96M +1.74% | -63.89M -75.89% | -50.85M +27.62% | -52.93M -530.34% | -60.67M +9.40% | -45.81M +28.30% | -44.58M +12.33% | -191.94M -262.62% | -52.20M +13.96% | -42.68M +6.82% | -38.85M +12.87% | -140.72M +26.68% | -274.45M -- |
Net Income Attributable to Owners of the Company | -29.24M -- | -100.66M -- | -35.72M -- | -38.86M -- | -55.04M -88.25% | -62.59M +37.81% | -48.88M -36.83% | -83.71M -115.42% | -68.14M -23.80% | -36.32M +41.97% | -70.25M -43.74% | -8.40M +89.97% | -66.96M +1.74% | -63.89M -75.89% | -50.85M +27.62% | -52.93M -530.34% | -60.67M +9.40% | -45.81M +28.30% | -44.58M +12.33% | -191.94M -262.62% | -52.20M +13.96% | -42.68M +6.82% | -38.85M +12.87% | -140.72M +26.68% | -274.45M -- |
Preferred Stock Dividends | 3.58M -- | -- -- | -- -- | 3.58M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income Attributable to Common Stockholders | -32.82M -- | -100.66M -- | -35.72M -- | -42.44M -- | -55.04M -67.70% | -62.59M +37.81% | -48.88M -36.83% | -83.71M -97.24% | -68.14M -23.80% | -36.32M +41.97% | -70.25M -43.74% | -8.40M +89.97% | -66.96M +1.74% | -63.89M -75.89% | -50.85M +27.62% | -52.93M -530.34% | -60.67M +9.40% | -45.81M +28.30% | -44.58M +12.33% | -191.94M -262.62% | -52.20M +13.96% | -42.68M +6.82% | -38.85M +12.87% | -140.72M +26.68% | -274.45M -- |
Other Comprehensive Income | 632.00K -- | 105.00K -- | -598.00K -- | -337.00K -- | -93.00K -114.72% | -90.00K -185.71% | -138.00K +76.92% | -1.56M -362.31% | -4.98M -5251.61% | -1.75M -1845.56% | -1.65M -1092.03% | 2.40M +253.85% | 3.72M +174.74% | 1.50M +185.67% | 1.20M +172.83% | 1.09M -54.65% | -310.00K -108.33% | 7.00K -99.53% | 1.16M -3.42% | -469.00K -143.15% | -133.00K +57.10% | -101.00K -1542.86% | 144.00K -87.55% | 41.00K +108.74% | -49.00K -- |
Total Comprehensive Income | -28.61M -- | -100.55M -- | -36.32M -- | -39.19M -- | -55.14M -92.73% | -62.69M +37.66% | -49.01M -34.96% | -85.26M -117.54% | -73.12M -32.62% | -38.07M +39.26% | -71.90M -46.69% | -6.00M +92.96% | -63.24M +13.51% | -62.39M -63.87% | -49.66M +30.94% | -51.84M -764.05% | -60.98M +3.58% | -45.80M +26.59% | -43.43M +12.54% | -192.40M -271.13% | -52.33M +14.18% | -42.78M +6.59% | -38.70M +10.88% | -140.68M +26.88% | -274.50M -- |
Total Comprehensive Income Attributable to Owners of the Company | -28.61M -- | -100.55M -- | -36.32M -- | -39.19M -- | -55.14M -92.73% | -62.69M +37.66% | -49.01M -34.96% | -85.26M -117.54% | -73.12M -32.62% | -38.07M +39.26% | -71.90M -46.69% | -6.00M +92.96% | -63.24M +13.51% | -62.39M -63.87% | -49.66M +30.94% | -51.84M -764.05% | -60.98M +3.58% | -45.80M +26.59% | -43.43M +12.54% | -192.40M -271.13% | -52.33M +14.18% | -42.78M +6.59% | -38.70M +10.88% | -140.68M +26.88% | -274.50M -- |
Basic EPS | -2.82 -- | -8.18 -- | -2.57 -- | -- -- | -3.19 -13.12% | -1.47 +82.03% | -0.2 +92.22% | -0.34 -- | -0.28 +91.22% | -0.15 +89.80% | -0.28 -40.00% | -0.03 +91.18% | -0.27 +3.57% | -0.26 -73.33% | -0.2 +28.57% | -0.21 -600.00% | -0.24 +11.11% | -3.59 -1280.77% | -3.48 -1640.00% | -0.65 -209.52% | -0.18 +25.00% | -2.89 +19.50% | -2.13 +38.79% | -6.62 -918.46% | -11.82 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.2 -- | -- -- | -0.24 -- | -3.59 -- | -3.48 -1640.00% | -- -- | -0.18 +25.00% | -2.89 +19.50% | -2.13 +38.79% | -- -- | -- -- |
Diluted EPS | -2.82 -- | -8.18 -- | -2.57 -- | -- -- | -3.19 -13.12% | -1.47 +82.03% | -0.2 +92.22% | -- -- | -0.28 +91.22% | -0.15 +89.80% | -0.28 -40.00% | -- -- | -0.27 +3.57% | -0.26 -73.33% | -0.2 +28.57% | -- -- | -0.24 +11.11% | -3.59 -1280.77% | -3.48 -1640.00% | -- -- | -0.18 +25.00% | -2.89 +19.50% | -2.13 +38.79% | -- -- | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.2 -- | -- -- | -0.24 -- | -3.59 -- | -3.48 -1640.00% | -- -- | -0.18 +25.00% | -2.89 +19.50% | -2.13 +38.79% | -- -- | -- -- |
You can ask Aime
What does Lyell Immunopharma do and what are its main business segments?What factors drove the changes in Lyell Immunopharma's revenue and profit?What guidance did Lyell Immunopharma's management provide for the next earnings period?What were the key takeaways from Lyell Immunopharma's earnings call?What is Lyell Immunopharma's gross profit margin?What is Lyell Immunopharma's latest dividend and current dividend yield?What is the revenue and EPS growth rate for Lyell Immunopharma year over year?What were the key takeaways from Lyell Immunopharma’s earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
